Need professional-grade analysis? Visit stockanalysis.com
$537.75M
85.69
120
N/A
Brainsway Ltd (BWAY) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at $15.85, up 3.39% from the previous close.
Over the past year, BWAY has traded between a low of $8.61 and a high of $26.04. The stock has gained 80.3% over this period. It is currently 39.1% below its 52-week high.
Brainsway Ltd has a market capitalization of $537.75M, with a price-to-earnings ratio of 85.69.
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Side-by-side comparison against top Healthcare peers.